Actinium Pharmaceuticals OverviewActinium Pharmaceuticals Net Income
Profitability analysis for ATNM.
Quarterly Net Income
-$5.52M
↑ 65.35% YoY
As of Mar 2026
Annual Net Income (TTM)
-$23.47M
↑ 48.43% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...